Navigation Links
WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Date:10/9/2007

SALEM, N.H., Oct. 9 /PRNewswire/ -- The Wellion Linus Blood Glucose Monitoring System, powered by WaveSense technology for high accuracy testing, recently received certification by the Netherlands Organization for Applied Scientific Research TNO ("TNO"). TNO is an independent group founded in 1932 that thoroughly tests and inspects medical devices. The Wellion Linus Blood Glucose also carries the CE Marking.

"Receiving the TNO approval is a testament to the quality and accuracy of WaveSense products," said Dr. E. van Ballegooie, one of the leading physicians in the Belgium/Netherlands/Luxembourg region. "Roche and Abbott are the other major brands to receive the TNO approval; this clearly demonstrates that WaveSense is one of the leading technologies in the world."

In addition to market leading features such as having a fast test time, small sample size, and large backlit display, the Wellion Linus's main feature is its ability to provide high accuracy test results due to its WaveSense technology. For a list of the other blood glucose monitors that have received TNO approval, see: http://www.tnokeur.nl/.

"TNO is known throughout Europe for their high standards and its tests are often more rigorous than the requirements for the mandatory CE Marking. We are honored to place the prestigious TNO seal on our WaveSense products. TNO certification is a tremendous advantage since we are penetrating demanding markets, such as The Netherlands, where users prefer very rigorous accuracy standards for home blood glucose monitoring systems," said Werner Trenker, CEO of MedTrust, distributor of WaveSense products in Europe.

WaveSense technology is a suite of patented technologies that enable high accuracy glucose monitoring products. WaveSense employs Dynamic Electrochemistry to extract a spectrum of information inaccessible to traditional static electrochemistry methods. WaveSense technology aids in
'/>"/>

SOURCE AgaMatrix
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...HESTER, Minn., Nov. 26 ...rd are at significantly increased risk of developi... findings of a Mayo Clinic study published this m...merican Academy of Pediatrics. , , The retr...7 patients with strabismus (misaligned eyes) and c...
(Date:11/26/2008)...dy Expanded to 406 Subjects , , FRANKLIN, M...s Inc. (OTC Bulletin Board: PLCSF) announced today...Food and Drug Administration (FDA) for its U.S. pi...any,s RenalGuard System(TM) and associated therap...y (CIN). , , The FDA also approved PLC,s re...
(Date:11/25/2008)...ISVILLE, Ky., Nov. 25 K...urgeons performed the fifth U.S. hand transplant o... at Louisville,s Jewish Hospital Hand Care Center ...began around noon and was completed shortly after ... http://www.newscom.com/cgi-bin/prnh/20081125/DC4...
(Date:11/25/2008)...TH SAN FRANCISCO, Calif., Nov. 25 ...velopment of novel therapeutics that target,prote...iseases, today,announced that data from two ongoi...iple myeloma will be presented at the upcoming 50t...ology (ASH). Carfilzomib is the first in a new cl...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 1Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 2Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 3Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 23343 1Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 23343 2Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference 23340 1Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference 23340 2Physicians Practice Promotes Key Executives 23337 1Physicians Practice Promotes Key Executives 23337 2
...t Randomized, Placebo-controlled Trial,Ever Conduc...linical Oncology, CHICAGO, June 04, 2007 /PRNewswi...ed, placebo-controlled clinical trial ever,conduct...L) showed,that ONTAK was more than twice as effect... patients with CTCL. [Abstract number 8026],The pr...
...With Follicular Lymphoma Reported,Today at ASCO An...ire/ -- GlaxoSmithKline plc,announced today long-t...e one-week course of frontline treatment with the ...ine I-131 Tositumomab) in,76 patients with newly d...a (NHL). This regimen was found to induce durable ...
Other Medicine Technology:Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
(Date:12/2/2008)...orld Wide Dictation Service, one of the premier le...ption, and legal dictation transcription, has joi... non-profit organization geared to the betterment ...amilies throughout Lower Westchester County, New Y...) December 3, 2008 -- World Wide Dictation Service...
(Date:12/2/2008)...oes your over-the-phone interpretation vendor cont...completed the call? , Was...orld of over-the-phone interpretation (OPI), every...er one minute can add up over the course of a bill...ganization employs an over-the-phone interpretatio...
(Date:12/2/2008)...rion Health announces that the SouthEast Alaska Re...a, has selected the Rhapsody™ Integration En...d, radiology, pharmacy, laboratory and business pr...to extend connectivity to statewide systems such a...ry) and AKAIMS (an MIS and clinical documentation ...
(Date:12/1/2008)... Including a patient,s ...meticulous reading from the radiologist interpreti...thetic approach, according to a study presented to...ety of North America (RSNA). , , "Our stud...ing and not as an anonymous case study," said lead...
Breaking Medicine News(10 mins):Health News:World Wide Dictation Service Teams up with TMATT for Local Thanksgiving Community Dinner 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 2Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 3
...ntified particular genes that are most prone to be...alled DNA promoter hypermethylation. Hypermethyla... normal cell development, to generate proteins tha...ehavior, or unregulated cell growth. So far, dat...
... between an extreme form of sleep disorder, REM Be...tia or parkinsonism. Patients with RBD have a hi...tia, Parkinsons disease or multiple system atrophy...pear to stem from a similar neurodegenerative orig...
...iasts and experts in the capital are strongly oppo...ng to recent reports of yet another application fi...l that the very idea of patenting knowledge like y..."Patenting of any kind is highly unjustified and w...
...age for mental illness does not increase usage and...who have children with mental illness, a Yale Scho... Services Research. Prior research has left polic...te parity laws will neither break the bank nor con...
Other Medicine News:Health News:Researchers Have Identified Cancer Promoter Genes 2Health News:Researchers Find Link Between Sleep Disorder and Dementia 2Health News:Yoga Enthusiasts Oppose Patenting Yoga Overseas 2Health News:Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending 2
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work.
Near PT test card/child recog/ playing cards 5 1/2" X 8".
Near point card/newspaper 8 to 48 point type 5 1/2" X 8".
Near point card 4 1/2 to 24 PT 5 1/2" x 8".
Medicine Products: